SCHEMBL6492165

SCHEMBL6492165

Cc1ccc2[nH]c3c(c2c1)C(=NNC(=N)N)CC(c1ccccc1)C3

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
KMT2A Q03164 4/20 0.40
HTT P42858 4/20 0.39
MAPT P10636 4/20 0.39
MEN1 O00255 2/20 0.39
GAA P10253 1/20 0.39
LMNA P02545 4/20 0.38
RB1 P06400 1/20 0.38
HSD17B10 Q99714 3/20 0.36
HPGD P15428 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GFER P55789 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
PIM1 P11309 2/20 0.36
CLK4 Q9HAZ1 1/20 0.36
RAB9A P51151 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
DRD2 P14416 1/20 0.34
DRD1 P21728 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6492163 1.00 ALDH1A1 (0.42) ALDH1A1KMT2AHTTMAPTMEN1
SCHEMBL6495347 0.88 MAPT (0.35) ALDH1A1KMT2AHTTMAPTGAA
SCHEMBL7128314 0.88 MAPT (0.35) ALDH1A1KMT2AHTTMAPTGAA
SCHEMBL6487428 0.88 MAPT (0.40) ALDH1A1KMT2AHTTMAPTMEN1
SCHEMBL6500241 0.88 PIM1 (0.47) ALDH1A1MAPTGAALMNAKDM4E
SCHEMBL6500243 0.88 PIM1 (0.47) ALDH1A1MAPTGAALMNAKDM4E
SCHEMBL6487430 0.88 MAPT (0.40) ALDH1A1KMT2AHTTMAPTMEN1
SCHEMBL6488296 0.78 PTGES (0.43) ALDH1A1KMT2AHTTMAPTMEN1
SCHEMBL6488300 0.78 PTGES (0.43) ALDH1A1KMT2AHTTMAPTMEN1
Hydrochloric Acid SCHEMBL7687327 0.76 ADORA2A (0.36) KMT2AHTTMAPTLMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6951881-B2 (1-substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands WYETH (US) 2005-10-04 US disclosed
US-20030232843-A1 (1-Substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands WYETH (US) 2003-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232843-A1 (1-Substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands HTR6, HTR5A, HTR1A ALDH1A1 1019/4885KMT2A 2933/4885HTT 424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.